162 related articles for article (PubMed ID: 7649256)
1. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor.
Rossi GC; Pan YX; Brown GP; Pasternak GW
FEBS Lett; 1995 Aug; 369(2-3):192-6. PubMed ID: 7649256
[TBL] [Abstract][Full Text] [Related]
2. Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception.
Rossi GC; Leventhal L; Pan YX; Cole J; Su W; Bodnar RJ; Pasternak GW
J Pharmacol Exp Ther; 1997 Apr; 281(1):109-14. PubMed ID: 9103486
[TBL] [Abstract][Full Text] [Related]
3. Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats.
Rossi GC; Standifer KM; Pasternak GW
Neurosci Lett; 1995 Sep; 198(2):99-102. PubMed ID: 8592651
[TBL] [Abstract][Full Text] [Related]
4. Morphine-6beta-glucuronide-induced hyperphagia: characterization of opioid action by selective antagonists and antisense mapping in rats.
Leventhal L; Silva RM; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 1998 Nov; 287(2):538-44. PubMed ID: 9808678
[TBL] [Abstract][Full Text] [Related]
5. Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Sheng XR; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Jun; 395(1-2):98-107. PubMed ID: 17398041
[TBL] [Abstract][Full Text] [Related]
6. Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions.
Pan YX; Xu J; Xu M; Rossi GC; Matulonis JE; Pasternak GW
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4917-22. PubMed ID: 19273844
[TBL] [Abstract][Full Text] [Related]
7. Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia.
Rossi GC; Brown GP; Leventhal L; Yang K; Pasternak GW
Neurosci Lett; 1996 Sep; 216(1):1-4. PubMed ID: 8892377
[TBL] [Abstract][Full Text] [Related]
8. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1.
Schuller AG; King MA; Zhang J; Bolan E; Pan YX; Morgan DJ; Chang A; Czick ME; Unterwald EM; Pasternak GW; Pintar JE
Nat Neurosci; 1999 Feb; 2(2):151-6. PubMed ID: 10195199
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligodeoxynucleotide targeting distinct exons of the cloned mu-opioid receptor distinguish between endomorphin-1 and morphine supraspinal antinociception in mice.
Sánchez-Blázquez P; DeAntoio I; Rodríguez-Díaz M; Garzón J
Antisense Nucleic Acid Drug Dev; 1999 Jun; 9(3):253-60. PubMed ID: 10435750
[TBL] [Abstract][Full Text] [Related]
10. Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor.
Rossi G; Pan YX; Cheng J; Pasternak GW
Life Sci; 1994; 54(21):PL375-9. PubMed ID: 8196473
[TBL] [Abstract][Full Text] [Related]
11. 14-Methoxymetopon, a very potent mu-opioid receptor-selective analgesic with an unusual pharmacological profile.
King MA; Su W; Nielan CL; Chang AH; Schütz J; Schmidhammer H; Pasternak GW
Eur J Pharmacol; 2003 Jan; 459(2-3):203-9. PubMed ID: 12524147
[TBL] [Abstract][Full Text] [Related]
12. Morphine and morphine-6beta-glucuronide-induced feeding are differentially reduced by G-protein alpha-subunit antisense probes in rats.
Silva RM; Rossi GC; Mathis JP; Standifer KM; Pasternak GW; Bodnar RJ
Brain Res; 2000 Sep; 876(1-2):62-75. PubMed ID: 10973594
[TBL] [Abstract][Full Text] [Related]
13. The contribution of MOR-1 exons 1-4 to morphine and heroin analgesia and dependence.
Klein G; Rossi GC; Waxman AR; Arout C; Juni A; Inturrisi CE; Kest B
Neurosci Lett; 2009 Jul; 457(3):115-9. PubMed ID: 19429175
[TBL] [Abstract][Full Text] [Related]
14. Antisense mapping DOR-1 in mice: further support for delta receptor subtypes.
Rossi GC; Su W; Leventhal L; Su H; Pasternak GW
Brain Res; 1997 Apr; 753(1):176-9. PubMed ID: 9125445
[TBL] [Abstract][Full Text] [Related]
15. Anatomical and functional correlation of the endomorphins with mu opioid receptor splice variants.
Abbadie C; Rossi GC; Orciuolo A; Zadina JE; Pasternak GW
Eur J Neurosci; 2002 Sep; 16(6):1075-82. PubMed ID: 12383236
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms.
Pan YX; Xu J; Bolan E; Abbadie C; Chang A; Zuckerman A; Rossi G; Pasternak GW
Mol Pharmacol; 1999 Aug; 56(2):396-403. PubMed ID: 10419560
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of dihydromorphine, 6-acetyldihydromorphine and dihydroheroin analgesia and their differentiation from morphine.
Gilbert AK; Hosztafi S; Mahurter L; Pasternak GW
Eur J Pharmacol; 2004 May; 492(2-3):123-30. PubMed ID: 15178355
[TBL] [Abstract][Full Text] [Related]
18. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Rebecca Sheng X; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Feb; 388(1-2):135-47. PubMed ID: 17156941
[TBL] [Abstract][Full Text] [Related]
19. Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO.
Leventhal L; Stevens LB; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 1997 Sep; 282(3):1402-7. PubMed ID: 9316853
[TBL] [Abstract][Full Text] [Related]
20. Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine.
Xu J; Lu Z; Narayan A; Le Rouzic VP; Xu M; Hunkele A; Brown TG; Hoefer WF; Rossi GC; Rice RC; Martínez-Rivera A; Rajadhyaksha AM; Cartegni L; Bassoni DL; Pasternak GW; Pan YX
J Clin Invest; 2017 Apr; 127(4):1561-1573. PubMed ID: 28319053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
